ArticleBiochemistry2025
BPTF Target Engagement by Acetylated H2A.Z Photoaffinity Probes.
Article in Biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- NanoBRET Tracer Development for Class I Bromodomain Target Engagement in Live Cells.Bioconjugate chemistry · 2026Article
- NanoBRET Tracer Development for Class I Bromodomain Target Engagement in Live Cells.bioRxiv : the preprint server for biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Histone variant H2A.Z has been increasingly associated with cancer progression, including cancers characterized by the dysregulated function of the epigenetic reader protein BPTF (bromodomain and PHD finger containing transcription factor). Despite this association, a direct interaction between acetylated H2A.Z and BPTF has not been validated in a physiological context, given the weak bromodomain-histone tail affinity. Here, we developed photoaffinity acetylated histone probes based on differentially acetylated H2A.Z isoforms I and II with an N-terminal diazirine and a C-terminal biotin tag for covalently capturing and enriching BPTF and new interactors. Photo-crosslinking experiments followed by SDS-PAGE revealed that recombinant BPTF bromodomain (BPTF BD) directly interacts with both isoforms of H2A.Z in an affinity-dependent and acetyl-lysine binding pocket-specific manner. In nuclear lysates prepared from A549 non-small cell lung cancer cells, acetylated H2A.Z isoform probes enriched endogenous BPTF as a photo-crosslinking target, but to a lesser extent than the canonical partner, H4K16ac. Finally, to determine the natural acetylation patterns of H2A.Z in a human cancer cell line, we used bottom-up proteomics to quantify the levels and patterns of acetylation on H2A.Z from A549 cells. Mono- and diacetylation were the predominant acetylation patterns identified, with patterns containing acetylation sites K4ac, K7ac, K11ac, and K15ac. These results indicate that our photoaffinity probes can capture transient epigenetic protein-protein interactions, while optimization of conditions for interactome analysis of these transient interactions will be necessary for identifying additional epigenetic regulators of H2A.Z.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.